চাৰ্ভাইকেল কেন্সাৰ
Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
ক’ত যাব
ভাৰতৰ 3 খন হস্পিতালত এই trial-ৰ বাবে ৰোগী ভৰ্তি কৰা হৈছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
Cervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places women at high risk for CC is human immunodeficiency virus (HIV), as impaired immune response against Human papillomavirus (HPV) may result in persistent HR-HPV infection, a critical risk factor for progression of HPV-related cervical oncogenesis. Progression of precancerous lesions among women living with HIV (WLH) is…
স্পন্সৰ: ইউনিভাৰ্চিটি অফ কেলিফৰ্নিয়া, আৰ্ভিন
ClinicalTrials.gov-ত NCT07209917
ৰেজিস্ট্ৰীত শেষবাৰ আপডেট কৰা হৈছিল 31 Jul 2026 · আমি পঢ়িছোঁ 20 Oct 2026